Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus

Virus Research

Volumn 56, Issue 2, 1998, Pages 157-167

  Ikeda, Masanori ^a   Sugiyama, Kazuo ^a   Mizutani, Tetsuya ^a   Tanaka, Torahiko ^a   Tanaka, Katsuaki ^b   Sekihara, Hisahiko ^b   Shimotohno, Kunitada ^c   Kato, Nobuyuki ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Dept Viral Oncol Inst Virus R   (Japan)

Author keywords

HCV replication; Hepatitis C virus; Human hepatocytes; Persistent infection

Indexed keywords

ALPHA INTERFERON; VIRUS PROTEIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; PERSISTENT INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL LINE; CLONE CELLS; ENDOPEPTIDASE K; HEPACIVIRUS; HUMANS; INTERFERON-ALPHA; LIVER; POLYMERASE CHAIN REACTION; RNA, VIRAL; TEMPERATURE; VIRUS LATENCY; VIRUS REPLICATION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0032143649     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(98)00063-X     Document Type: Article

References (56)

1. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-born non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
2. Cribier B., Schmitt C., Bingen A., Kirn A., Keller F. In vitro infection of peripheral blood mononuclear cells by hepatitis C virus. J. Gen. Virol. 76:1995;2485-2491.
3. Ferri C., Monti M., Civita L.L., Longombardo G., Greco F., Pasero G., Gentilini P., Bombardieri S., Zignego A.L. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood. 82:1993;3701-3704.
4. Ferri C., Civita L.L., Zignego A.L., Pasero G. Hepatitis-C-virus infection and cancer. Int. J. Cancer. 71:1997;1113-1115.
5. Gabrielli A., Manzin A., Caniglia M.L., Paolucci S., Danieli M.G., Clementi M. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinemia. Clin. Exp. Immunol. 97:1994;87-93.
6. Gretch D.R., Polyak S.J., Wilson J.J., Carithers R.L., Perkins J.D., Corey L. Tracking hepatitis C virus quasi-species major and minor variants in symptomatic and asymptomatic liver transplant recipients. J. Virol. 70:1996;7622-7631.
7. Gunji T., Kato N., Hijikata M., Hayashi K., Saitoh S., Shimotohno K. Specific detection of positive and negative stranded hepatitis C viral RNA using chemical RNA modification. Arch. Virol. 134:1994;293-302.
8. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA. 88:1991;5547-5551.
9. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Ohkoshi S., Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem. Biophys. Res. Commun. 175:1991;220-228.
10. Hijikata M., Mizushima H., Akagi T., Mori S., Kakiuchi N., Kato N., Tanaka T., Kimura K., Shimotohno K. Two distinct proteinase activities required for the processing of a putative nonstructural protein of hepatitis C virus. J. Virol. 67:1993;4665-4675.
11. Hijikata M., Mizushima H., Tanji Y., Komoda Y., Hirowatari Y., Akagi T., Kato N., Kimura K., Shimotohno K. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc. Natl. Acad. Sci. USA. 90:1993;10773-10777.
12. Hijikata M., Mizuno K., Rikihisa T., Shimizu Y.K., Iwamoto A., Nakajima N., Yoshikura H. Selective transmission of hepatitis C virus in vivo and in vitro. Arch. Virol. 140:1995;1623-1628.
13. Ikeda M., Kato N., Mizutani T., Sugiyama K., Tanaka K., Shimotohno K. Analysis of cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes. J. Hepatol. 27:1997;445-454.
14. Ito T., Mukaigawa J., Zuo J., Hirabayashi Y., Mitamura K., Yasui K. Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titer infectious virus. J. Gen. Virol. 77:1996;1043-1054.
15. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA. 87:1990;9524-9528.
16. Kato N., Ootsuyama Y., Tanaka T., Nakagawa M., Nakazawa T., Muraiso K., Ohkoshi S., Hijikata M., Shimotohno K. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res. 22:1992;107-123.
17. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkoshi S., Shimotohno K. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J. Virol. 67:1993;3923-3930.
18. Kato N., Ootsuyama Y., Sekiya H., Ohkoshi S., Nakazawa T., Hijikata M., Shimotohno K. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J. Virol. 68:1994;4776-4784.
19. Kato N., Nakazawa T., Mizutani T., Shimotohno K. Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem. Biophys. Res. Commun. 206:1995;606-614.
20. Kato N., Ikeda M., Mizutani T., Sugiyama K., Noguchi M., Hirohashi S., Shimotohno K. Replication of hepatitis C virus in cultured non-neoplstic human hepatocytes. Jpn. J. Cancer Res. 87:1996;787-792.
21. Kato, N., Ikeda, M., Sugiyama, K., Mizutani, T., Tanaka, T., Shimotohno, K., 1998. Hepatitis C virus population dynamics in in vitro HCV-infected lymphocytes and hepatocytes. J. Gen. Virol. 79, 1859-1869.
22. Kojima M., Osuga T., Tsuda F., Tanaka T., Okamoto H. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selected replication of hepatitis C virus in chimpanzees. Virology. 204:1994;665-672.
23. Kooi C., Cervin M., Anderson R. Differentiation of acid-pH-dependent and -nondependent entry pathway for mouse hepatitis virus. Virology. 180:1991;108-119.
24. Kuo G., Choo Q.L., Alter H.J., Gitnick G.L., Redwker A.G., Purcell R.H., Miyamura T., Dienstag J.L., Alter M.J., Stevens C.E., Tegtmeier G.E., Bonino F., Colombo W.S., Lee W.S., Kuo C., Berger K., Shuster J.R., Overby L.R., Bradley D.W., Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:1989;362-364.
25. Lanford R.E., Sureau C., Jaco J.R., White R., Fuerst T.R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology. 202:1994;606-614.
26. Lanford R.E., Chavez D., Chisari F.V., Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J. Virol. 69:1995;8079-8083.
27. Lawal Z., Petrik J., Wong V.S., Alexander G.J.M., Allain J.P. Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology. 228:1997;107-111.
28. Lerat H., Berby F., Trabaud M.A., Vidalin O., Major M., Trepo C., Inchauspe G. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J. Clin. Invest. 97:1996;845-851.
29. Luppi M., Ferrari M.G., Bonaccorcio G., Longo G., Narni F., Barozzi P., Marasca R., Mussini C., Torelli G. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia. 10:1996;351-355.
30. Major M.E., Feinstone S.M. The molecular virology of hepatitis C. Hepatology. 25:1997;1527-1538.
31. Mizutani T., Kato N., Hirota M., Sugiyama K., Murakami A., Shimotohno K. Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells. Biochem. Biophys. Res. Commun. 212:1995;906-911.
32. Mizutani T., Kato N., Masanori I., Sugiyama K., Shimotohno K. Long-term human T-cell Culture System supporting hepatitis C virus replication. Biochem. Biophys. Res. Commun. 277:1996;822-826.
33. Mizutani T., Kato N., Saito S., Ikeda M., Sugiyama K., Shimotohno K. Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus Type 1-infected cell line, MT-2. J. Virol. 70:1996;7219-7223.
34. Muller H.M., Pfaff E., Goeser T., Kallinowski B., Solbach C., Theilmann L. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J. Gen. Virol. 74:1993;669-676.
35. Nakajima N., Hijikata M., Yoshikura H., Shimizu Y.K. Characterization of long-term cultures of hepatitis C virus. J. Virol. 70:1996;3325-3329.
36. Noguchi M., Hirohashi S. Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient. In Vitro Cell. Dev. Biol. 32:1996;135-137.
37. Novak J.E., Kirkegaard K. Improved method for detecting poliovirus negative strands used to demonstrate specificity of positive-strand encapsidation and the ratio of positive to negative strands in infected cells. J. Virol. 65:1991;3384-3387.
38. Ohkoshi S., Kojima H., Tawaraya H., Miyajima T., Kamimura T., Asakura H., Satoh A., Hirose S., Hijikata M., Kato N., Shimotohno K. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Jpn. J. Can. Res. 81:1990;550-552.
39. Poli G., Orenstein J.M., Kinster A., Folks T.M., Fauci A.S. Interferon-α but not AZT suppresses HIV expression in chronically infected cell lines. Science. 244:1989;575-577.
40. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., Choo Q.L., Houghton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6547-6549.
41. Saito S., Kato N., Hijikata M., Gunji T., Itabashi M., Kondo M., Tanaka K., Shimotohno K. Comparison of hypervariable regions (HVR1 and HVR2) in positive- and negative-stranded hepatitis C viris RNA in cancerous and noncannerous liver tissue, peripheral blood mononuclear cells, and serum from a patient with hepatocellular carcinoma. Int. J. Cancer. 67:1996;199-203.
42. Seipp S., Mueller H.M., Pfaff E., Stremmel W., Theilmann L., Goeser T. Establishment of persistent hepatitis C virus infection and replication in vitro. J. Gen. Virol. 78:1997;2467-2476.
43. Sekiya H., Kato N., Ootsuyama Y., Nakazawa T., Yamauchi K., Shimotohno K. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1. Int. J. Cancer. 57:1994;664-670.
44. Shimizu Y.K., Yoshikura H. Multicycle infection of hepatitis C virus in cell culture and inhibition by α and β interferons. J. Virol. 68:1994;8406-8408.
45. Shimizu Y.K., Iwamoto A., Hijikata M., Purcell R.H., Yoshikura H. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc. Natl. Acad. Sci. USA. 89:1992;5477-5481.
46. Shimizu Y.K., Purcell R.H., Yoshikura H. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc. Natl. Acad. Sci. USA. 70:1993;6037-6041.
47. Shimizu Y.K., Feinstone S.M., Kohara M., Purcell R.H., Yoshikura H. Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology. 23:1996;205-209.
48. Shimizu Y.K., Igarashi H., Kanematu T., Fujiwara K., Wong D.C., Purcell R.H., Yoshikura H. Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J. Virol. 71:1997;5769-5773.
49. Shimotohno K. Hepatitis C virus as a causative agent of hepatocellular carcinoma. Intervirology. 38:1996;162-169.
50. Silvestri F., Pipan C., Barillari G., Zaja F., Fanin R., Infanti L., Russo D., Falasca E., Botta G.A., Baccarani M. Prevalence of hepatitis C virus infection in patient with lymphoproliferative disorder. Blood. 87:1996;4296-4301.
51. Sugiyama K., Kato N., Ikeda M., Mizutani T., Shimotohno K., Kato T., Sugiyama Y., Hasumi K. Hepatitis C virus in pelvic lymph nodes and female reproductive organs. Jpn. J. Cancer Res. 88:1997;925-927.
52. Sugiyama K., Kato N., Mizutani T., Ikeda M., Tanaka T., Shimotohno K. Genetic analysis of the hepatitis C virus (HCV) genome from HCV-infected human T-cells. J. Gen. Virol. 78:1997;329-336.
53. Takamizawa A., Mori C., Fuki I., Manabe S., Murakami S., Fujita J., Onishi E., Andoh T., Yoshida I., Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65:1991;1105-1113.
54. Tanaka T., Kato N., Cho M.J., Shimotohno K. A novel sequence found at the 3′ terminus of hepatitis C virus genome. Biochem. Biophys. Res. Commun. 215:1995;744-749.
55. Weiner A.J., Brauer M.J., Rosenblatt J., Richman K.H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q.-L., Houghton M., Han J. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology. 180:1991;842-848.
56. Zibert A., Schreier E., Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology. 208:1995;653-661.